Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2012174262) FORMULATIONS AND METHODS OF TREATING SUBJECTS HAVING CENTRAL NERVOUS SYSTEM, ENDOCRINE, INFLAMMATORY OR CARDIOVASCULAR DISORDERS OR AT-RISK THEREOF WITH HIGHLY PURIFIED OMEGA-3 FATTY ACID FORMULATIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2012/174262 International Application No.: PCT/US2012/042489
Publication Date: 20.12.2012 International Filing Date: 14.06.2012
IPC:
A61K 31/20 (2006.01) ,A61K 31/185 (2006.01) ,A61K 9/20 (2006.01) ,A61K 9/16 (2006.01) ,A61P 3/10 (2006.01) ,A61P 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
20
having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
16
Agglomerates; Granulates; Microbeadlets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
Applicants:
CENESTRA LLC; 234 Church Street New Haven, CT 06510, US (AllExceptUS)
SANFILIPPO, Louis [US/US]; US (UsOnly)
FEUERSTEIN, Seth [US/US]; US (UsOnly)
CORIC, Ann [US/US]; US (UsOnly)
Inventors:
SANFILIPPO, Louis; US
FEUERSTEIN, Seth; US
CORIC, Ann; US
Agent:
LAVENUE, Teresa; Hogan Lovells US LLP 555 Thirteenth Street, NW Washington, DC 20004, US
Priority Data:
61/496,89314.06.2011US
Title (EN) FORMULATIONS AND METHODS OF TREATING SUBJECTS HAVING CENTRAL NERVOUS SYSTEM, ENDOCRINE, INFLAMMATORY OR CARDIOVASCULAR DISORDERS OR AT-RISK THEREOF WITH HIGHLY PURIFIED OMEGA-3 FATTY ACID FORMULATIONS
(FR) FORMULATIONS ET MÉTHODES DE TRAITEMENT DE SUJETS AYANT DES TROUBLES DU SYSTÈME NERVEUX CENTRAL, ENDOCRINIENS, INFLAMMATOIRES OU CARDIOVASCULAIRES OU PRÉSENTANT UN RISQUE D'EN SOUFFRIR, PAR DES FORMULATIONS D'ACIDES GRAS OMÉGA 3 EXTRÊMEMENT PURIFIÉS
Abstract:
(EN) The present invention provides highly purified omega-3 fatty acid formulations. Unit dosage forms of the omega-3 fatty acid formulations are also provided herein. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular system, central nervous, endocrine or inflammatory disorders by providing a formulation of the invention to a patient in need thereof.
(FR) La présente invention concerne des formulations d'acides gras oméga 3 extrêmement purifiés. La présente invention concerne également des formes posologiques unitaires des formulations d'acides gras oméga 3. L'invention concerne également des procédés d'utilisation des formes posologiques pour traiter une variété de troubles du système cardiovasculaire, nerveux central, endocrinien ou inflammatoire en donnant une formulation de l'invention à un patient qui en a besoin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)